Fecal microbiota transplantation from lean donors to patients with obesity and metabolic syndrome (MS) has shown significant improvement in insulin sensitivity after 6 weeks with FMT from a lean donor (allogeneic) vs. FMT autologous or aFMT (96). This evidence concerns the gene INS and metabolic syndrome.